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Influence of Langer hans Cells on the Survival of H-Y Incompatible Skin 
Grafts in Rats 
HoNe-Duo CHEN, M.D. * AND WILLYS K. SILVERS, PH.D. 
Department of Human Genetics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, U.S.A. 
Evidence is presented that Langer hans cells (LCs) play 
an important role in the rejection of H-Y incompatible 
skin grafts in BN rats. Not only are small male trunk 
skin isografts much more likely to be rejected by BN 
females than similarly sized male foot pad, tail, and ear 
skin transplants, all of which possess fewer LCs than 
trunk skin, but the survival of male trunk skin grafts 
can be prolonged by replacing their LC population with 
allogeneic female cells. 
In rats, as in mice, there is a weak transplantation antigen-
known as the H-Y antigen-associated with theY chromosome 
(1]. As a consequence, females may reject skin grafts from male 
donors of the same inbred strain. Their ability to do so depends 
upon a number of factors including their genotype and the size 
of the graft [2,3). Small grafts are more likely to be rejected 
than large grafts. The survival of H- Y incompatible skin grafts 
also depends upon their origin. This is especially the case in 
BN rats when~ small male trunk skin grafts are usually rejected 
within 50 days, while similarly sized grafts .of ear or tail origin 
frequently survive >100 days [3). This situation also occurs in 
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mice, though the differences are much less pronounced. In 
C57BL/6 mice, male tail and ear skin isografts persist a little 
longer on female than male trunk skin grafts of the same size 
[ 4]. Recently, it has been suggested that the better survival of 
H-Y incompatible mouse tail skin grafts as compared with 
those of trunk skin may result from their paucity of Langer hans 
cells (LCs). Thus; Bergstresser and his colleagues [5] suggest 
that "Langer hans cell-poor skin may be lacking certain essential 
functions relating to the induction and expression of immune 
reactivity." The following investigation provides further evi-
dence for this contention. Indeed, not only have we found that 
there is a con-elation between LC density and the smvival of 
different kinds of H-Y incompatible skin grafts in rats, but we 
have been able to prolong the survival of H -Y incompatible 
trunk skin grafts in this species by replacing their LC population 
with allogeneic female cells. 
MATERIALS AND METHODS 
Animals 
The major histocompatibility complex (MHC) incompatible BN/ Ss 
(BN) and Lewis/ Ss (Lew) rats employed in this study, as well as their 
F1 hybrids (Lew/ BN), were domestically produced. 
Abbreviations: 
BN: BN/Ss rats 
LC: Langerhans cell 
Lew: Lewis/ Ss rats 
Lew/ BN: (Lewis X BNlF1 hybrid rats 
MHC: major histocompatibility complex 
MST: median survival time 
PBS: phosphate-buffered saline 
SOF: sole of foot 
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Shin Grafting 
Skin grafting was carried out according to procedures described 
elsewhere [6). Donors and recipients were at least 2 months old. Unless 
stated otherwise, grafts were ca refully prepared to measure 1 cm2 , but 
varied fro m 0.5-1.5 cm2 when remeasured at primary inspection (9 days 
post grafting) to more accurately assess their size. After primary in-
spection, grafts were inspected daily for 30 clays and at least twice a 
week thereafter. 
Tolerance Induction. 
Tolerance was inclucecl by injecting rats, less than 12 h old, with 50 
x 10'; Lew/ BN male F, hybrid bone marrow cells [7]. 
Statistics 
Median su rvival times (MSTs) of skin grafts were determined using 
a computer program employing probit transformation [8]. Probability 
(p) values were calculated with the "chi-square" test. 
LC Enumeration 
LCs were identified with an anti-Ia monoclona l (lgM) antibody [9] 
employing an indirect immunofluorescence proceclm-e [10]. 
Because LC populations display regional differences in their distri-
butions, different methods had to be employed to determine the number 
of LCs in skin grafts derived from trunk, tail, ear, and sole of foot 
(SOF). In all instances the number of LCs was cou nted with the a iel of 
a grid (calibrated with a micrometer). 
In the case of trunk skin, the average number of hair fo llicles/ mm2 
was estimated and the number of LCs on the wall of each of 10 follicles 
(selected for t heir intact natm-e) counted. Once the average number of 
LCs/mm2 of in terfollicular area was estimated, the tota l number of 
cells/mm2 could be ascertained (average number of cells/mm2 of inter-
fo llicular area + average number of cells/follicle X average number of 
fo llicles/mm2 ). 
Since the ha i1· fo llicles of the ear are not located as deep in the 
dermis as those originating in the trunk, separated ear epidermis 
includes a population of usually in tact, and evenly distributed follicles. 
Accordingly, it was possible to estimate the number of LCs in ear skin 
by directly coun ting the number/mm2• 
Rat tail skin, like mouse tail skin [11], is composed of a regular 
arrangement of slightly elevated scales aJTangecl in rings ar ound the 
long axis. In the regions between the rings, 4- 5 hairs (we estimated 5 in 
all of om calculations), directed backward, emerge under each scale. 
Since the hair follicles, like those in trunk skin, are often damaged 
when the epidermis is separated from the dermis, the number of LCs/ 
follicle was estimated on the basis of those counted in 10 intact. follicles. 
The number of LCs in 2 or 3 scales, including the interscale regions, 
was also counted and their areas measured. From these estimates the 
number of LCs/mm2 could be ascertained. 
The number of LCs in SOF epidermis was estimated as follows. 
There are 5 or 6 nodules in each foot pad and usually the density of 
LCs in these nodules is Jess than in the in ternodular a rea. S ince a bout 
25% of SOF skin is composed of nodular ar ea, the numbers of ce lls/ 
mm2 in nodular and in ternodular areas, respectively, were counted and 
the average number of ce lls/mm2 calculated according to the formula: 
number/mm2 nodule area X \1., + number/mm2 internodular area X 'Y•. 
Finally, to assess the a bili ty of the indirect immunofluorescence 
method to reveal LCs in neonatal skin, it was also stained for ATPase 
[12]. 
Each of these determinations was caJTied out on skin samples from 
6 different BN males with 2 "samples" taken from each animal. 
RESULTS 
Densities and Distributions of LCs 
There are striking differences in th e de nsities and distribu-
tions of LCs in th e various kinds of e pidermis examined (Table 
I ). While they are numerous in the interfollicular areas of trunk 
and ear epidermis, they occur much less . frequently in the 
nodular areas of the SOF, and only very rarely are found in the 
scale areas of the tail (although they are well represented in 
interscale areas). On the other hand, LCs are associated with 
the h air follicles of a ll tracts. Indeed, it is our impression that 
it is m a inly the much greater size of trunk hair follicles than 
ear (and the fewer number of follicles in tail skin , and t h eir 
absen ce in SOF skin) that is responsible for the significantly 
greater density of LCs in trunk skin. 
T o obtain information on t h e density of LCs in n eonatal rat 
skin, BN skin from males less than 12 h old was stained by the 
same indirect immunofluorescence method employed for adult 
epidermis. Exceedingly few fluorescent cells were discernible 
so few in fact that t h ey were lacking in some fields. Moreover: 
t h e cells t hat were revealed were indistin ct a nd deficient in 
dendrites. To exclude t h e possibility t h at t his pau city of fluo-
rescent cells r esulted from Ia antigen-deficient LCs rath er t han 
from a deficiency in t h e cells themselves, n eon atal BN male 
skin was a lso stained for ATPase. Although this procedm-e 
r evealed s ignificantly more LCs th a n t h e immunofluorescence 
procedure, there were still significan tly fewer cells associated 
with t h e developing h air follicles, as well as interfollicularly, 
t h a n t h er e were in ad ult skin (Table I) . Moreover, t h e cells 
were not as dendritic as in adult s kin. 
Survival of H- Y Incompatible SOF Grafts 
Although we previously reported [3] that small BN male skin 
grafts which originate from th e tail or ear are more likely to be 
accepted by BN fem ales than H-Y incompatible trunk skin 
grafts of similar s ize (Table II) , it was o nly after we discovered 
th at th e SOF also possesses a paucity of LCs t hat we initiated 
experiments to determine whether H-Y incompatible grafts 
prepared from this region also survive longer th an BN trunk 
skin grafts. Two types of SOF grafts were employed; those 
prepar ed from t h e e ntire foot pad and trimmed to m easure 1 
cm
2 
a nd those consisting of only a foot pad nodule (.03-.06/ 
cm
2
). In view of the fact that large H-Y incompatible trunk skin 
grafts are tolerated more often than small grafts [2], the results 
were som ewh at surpris ing (Table III) . Whereas, as a n t icipated 
from the low density of L Cs in the foot pad, most of the grafts 
prepared from this r egion survived > 100 days, t h e much smaller 
nodule grafts were more readily accepted th an t hose prepared 
from the e n t ire SOF (p < 0.05). 
Influence of A ltering the LC Population of H- Y Incompatible 
Trunk Skin Grafts on Their Survival 
While t h e results noted above are consistent with th e premise 
that t h e immunogenicity of H-Y incompatible BN skin grafts 
TABLE I. Densities of epidermal LCs in BN male rat shin from 
different sites 
Site" 
Trunk (adult) 
Ear 
T ail 
SOF 
SOF (nodule) 
Trunk (neonate) 
Cells/ mm2 
(mean ± SE) 
1330 ± 32.5 
641 ± 49.7 
353 ± 21.9 
253 ± 11.1 
121 ± 11.9 
109 ± 11.8 
" Seventeen fields (approxin1ately 1 mm2 ) were coun ted in each of 12 
specimens from each site. All specimens stained with incijrect in}l11U-
nofluorescence method except neonatal skin which was stained for 
ATPase. 
TABLE II . Survival of small" H-Y incompatible trunh, ear, and tail 
shin. grafts in BN females" 
Gra ft No. 
origin of grafts 
Trunk 28 
Ear 16 
Tail 18 
"From 0.5-1.5 cm2 • 
6 From Chen and Silvei·s [3). 
MST ± SE 
(days) 
12.8 ± 1.07 
>100 
>100 
No. accepted 
> 100 days (%) 
0 (0) 
10 (62) 
9 (50) 
TABLE III. Survival of H -Y incompatible SOF grafts in BN females 
Percent 
Graft Size (cm2 ) No. Survival (days) accepted 
> 100 days 
SOF .09-1.5 14 39, 2 X 53, 2 X 62, 57 
81, 8 X >100 
SOF nodule .03-.06 20 58, 19 X > 100 95 
22 CHEN AND SILVERS 
TABLE IV. Su.rvival of H-Y incompatible BN shin grafts" after 
being maintained on. d ifferent primary hosts for 150 days 
Primary Langerhans No. MS'I'±SE P ercent 
host. cell grafts (days) accepted popula tion > 100 days 
BN o 28 12.8 ± 1.07 0 
BN '? BN '? 8 11.8 ± 1.14 0 
BNo'' BN o + F,o 10 14.0 ± 1.24 0 
BN '?" BN 2 + F, o 15 19.6 ± 1.13 0 
Lew'?'' Lew '?+ F, o 15 > 100 60 
"Grafts varied fTom 0.5-1.5 cm2• 
• Injected i. v. at birth with 50 x 10,; Lew/ BN F, o bone marrow ceLls. 
is somehow related to their density of LCs, it is nevertheless 
circumstantial evidence. To obtain more direct evidence, we 
determined whether we could prolong the survival of small BN 
male trunk skin isografts on syngeneic females by altering their 
LC populations. This was achieved by taking advantage of the 
fact t hat LCs aTe of bone manow origin [13,14] with a turnover 
time of about 4 months [15]. Thus, BN male skin grafts main-
tained on BN females for more than 4 months should have a 
BN female LC population, and such grafts maintained on Lew 
females toleran t of Lew/ BN male F 1 bone marrow cells for a 
similru· period should possess a predominantly Lew female LC 
population (as well as an unknown number ofF, hybrid male 
cells) . Accordingly, lru·ge (4-6.25 cm2) male skin isografts were 
maintained on eith er normal BN females (such grafts are often 
accepted because oftheil· size [2)), BN females tolerant of Lew/ 
BN F, male bone marrow cells, BN males also injected at bil·th 
with F, male bone marrow cells, or Lew fe males rendered 
tolerant at bil·th with F, male cells. After these grafts had been 
in residence on theil· primaxy hosts for 150 days, they were 
removed, cut into 1 cm2 pieces, and regrafted to panels of 
normal BN females. The resu lts (Table IV) indicate that while 
substituting BN female (and an unknown number ofF , male) 
LCs for BN male LCs in BN male grafts has little or no 
influence on the ability of the grafts to survive on female hosts, 
repopulating such grafts with Lew female (and F, male) cells 
significantly enh ances theil· survival on such recipients. Indeed, 
following such treatment, 9 grafts displayed no signs of rejection 
and survived > 100 days and the 6 grafts that were rejected 
survived longer (22, 26, 26, 49, 57, and 60 days) than the MST 
of normal BN male skin grafts or of BN male skin grafts 
repopulated with BN (and F , hybrid male) cells. 
It follows that if replacing the native LC population of BN 
male skin grafts with Lew female cells is responsible for many 
of them being accepted by BN females, then they should not 
SUl'vive on second BN female hosts after they have reacquired 
a BN LC population. This was the case as when the 9 male BN 
grafts t hat had been accepted for > 100 days by BN females 
after residing on Lew females for 150 days were removed (at 
120 days) and regrafted to second BN female hosts, all became 
necrotic. Indeed, 8 of these grafts were gone within 11 days and 
the last graft survived for only 18 days. As a control for this 
experiment, 8 male BN skin grafts that had resided on tolerant 
Lew males for 150 days and on BN males for 120 days were 
remov.ed and reg:rafted to second BN males. For some unknown 
reason, perhaps associated with the trauma of regrafting the 
skin a third tin1e, only 5 of these grafts were permanently 
accepted (all traces of the 3 tha t did not survive were gone 
within 12 days) . Nevertheless, the difference between experi-
mental and control groups is statistically significant (p < 0.025). 
DISCUSSION 
These results provide strong support for the contention that 
LCs play a major role in the rejection of H-Y incompatible skin 
grafts in BN rats. Not only are male skin isografts prepared 
from regions such as the tail and SOF that have reduced 
numbers of LCs more likely to be accepted by females than 
similarly s ized trunk skin grafts, bu t the survival of the latter 
transplants can be enhanced by replacing their LCs with Lew 
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female cells. How supplanting the LCs ofBN male skin isografts 
with Lew female LCs promotes their SUJ"vival remains to be 
determined. However, since LCs are believed to be antigen-
presenting cells it is tempting to speculate that MHC restriction 
is involved [16], i.e., that in such grafts H-Y is recognized by 
the host in association with the MHC of Lew rather than in 
association with self MHC. Indeed this explanation is in accord 
with the fact that the survival of BN male skin isografts is 
unaffected when their LCs are replaced with BN female LCs. 
On the other hand, it is just as possible that BN male skin 
grafts bearing Lew female LCs often are accepted by BN 
females because their LC populations are acutely rejected . 
Indeed, the acute rejection of Lew female LCs in BN male 
trunk skin grafts would result in a transplant which, like ear, 
tail , and SOF grafts, possessed a paucity of LCs. 
It is also important to note that the immunogenicity of BN 
male skin grafts maintained on Lew females seems to be re-
stored after they reacquire a BN LC population. This too 
indicates that LCs play an important role in provoking trans-
plantation immunity and that a temporary deficiency of these 
cells can alter the fate of weakly incompatible grafts. Still 
further evidence incriminating the LC in the rejection process 
is provided by the fact that tiny H-Y incompatible SOF nodules, 
which possess significantly fewer LCs than the epidermis that 
surrounds them [17], are more readily accepted than larger 
grafts prepared from the entire foot pad. Indeed, this observa-
t ion provides an exception to the rule that when only weak 
histoincompatibilities prevail, small grafts are more likely to be 
rejected than large grafts [18]. 
The fact that at birth, rat, as well as mouse [11], skin is 
deficient in LCs may also contribute to the privilege afforded 
neonatal skin grafts. Thus, in rat H-Y incompatible situations 
[19], as well as with H-Y [20] and skin alloantigenic differences 
in mice [21], such grafts not only often are accepted but are 
tolerogenic, i.e., they induce unresponsiveness to subsequent 
adul t grafts of the same genotype. 
The observation that the putatively acute rejection of Lew 
female LCs in BN male trunk skin isografts evidently had no 
adverse affect on these grafts also deserves comment. This is in 
accord with the fact that syngeneic mouse skin grafts bearing 
a chimeric population of LCs incompatible with respect to the 
en tire MHC (H-2 region) are permanently accepted [15]. On 
the other hand, trunk skin grafts incompatible only with respect 
to the I region of H-2 (plus the S and G regions) are acutely 
rejected [22,23]. Al though these situations seem incongruous 
ti·om the standpoint that LCs are purported to be the only cell 
of the skin to express Ia antigens [24-27] (but see [28,29]) , we 
believe they can be explained by the recent finding tha t Ia 
antigens are expressed in epidermal keratinocytes in graft-ver-
sus-host disease [30,31]. Thus, if one assumes that host-versus-
graft reactions can likewise induce th e expression of Ia antigens 
by keratinocytes, all of the epidermal cells of Ia incompatible 
but not of LC chimeric grafts should possess these antigens. 
Finally, it should be emphasized that the ability to prolong 
the survival of H-Y incompatible BN skin grafts by merely 
reducing their effective LC populations, undoubtedly is a con-
sequence of the histocompatibili ty barrier involved. Thus, we 
would not expect similar proceduJ"es to be effective in altering 
the survival of MHC incompatible grafts or, for that matter, 
the survival of grafts bearing a multiplicity of weak transplan-
tation antigens [15,32]. 
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Inhibition of a Langerhans Cell-Mediated Immune Response by 
Treatment Modalities Useful in Psoriasis* 
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Neither the pathogenesis of psoriasis nor the mecha-
nism whereby seemingly diverse therapies alter the dis-
ease is understood. In this study, several antipsoriatic 
agents were tested for their effects on the skin cell 
lymphocyte reaction (SLR), an immunologic assay in 
which HLA-DR antigens on Langerhans cells (LC) stim-
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ulate proliferation of allogeneic lymphocytes . Every 
agent tested (cortisol, methotrexate, hyperthermia, an-
thralin) inhibited the SLR at therapeutic dose levels. By 
contrast, a variety of antibiotics, an anti-inflammatory 
agent, and lithium carbonate and propranolol, two drugs 
known to be ineffective in psoriasis, failed to inhibit the 
FCS: fe tal calf serum 
FDA: fluorescein diacetate 
CHJdThd: trit iated thymidine 
HLA-DR antigen: the human equiyalent of the murine Ia or 
immune response-associated antigen 
LC: Langerhans cells 
8-MOP: 8-methoxypsoralen 
MTX: methotrexate . 
PBML: peripheral blood mononuclear leukocytes 
PBS: phosphate-buffered saline 
PUV A: photoactivated 8-methoxypsoralen 
SLR: skin cell lymphocyte reaction 
